Company No: 07857868 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		2026		2025
		£		£
Fixed assets		1,755		2,711
Current assets		89,827		120,378
Prepayments and accrued income		6,719		4,463
Creditors: amounts falling due within one year		( 18,920)		( 13,298)
Net current assets		77,626		111,543
Total assets less current liabilities		79,381		114,254
Accruals and deferred income		( 4,327)		( 4,202)
Net assets		75,054		110,052
Capital and reserves		75,054		110,052

For the financial year ending 31 May 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Magnex Scientific Ltd (registered number: 07857868) were approved and authorised for issue by the director on 26 October 2026 and were signed on its behalf by:

D L Rayner Director

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 07857868). The address of its registered office is C/O Gravita Oxford Llp First Floor, Park Central, 40/41 Park End Street, Oxford, OX1 1JD, United Kingdom.

2. Employees

	2026		2025
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including the director	1		1